JPRN-jRCT1051180014尚未招募未知
Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with Influenza
Kato Kentaro0 个研究点目标入组 40 人开始时间: 2018年12月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- none 至 15 years old（—）
- 性别
- All
入选标准
- •1)axillary temperature more than 37.5 degree
- •2)a positive rapid antigen test for influenza virus
- •3)a symptom duraiton of no more than 36 hours
- •4)hospitalized patient
- •5)body weight more than 10kg
排除标准
- •1)patients who have suffered from bacterial infection or other viral infection within one week from the start of the study
- •2)patients who received recipes of Baloxavir marboxil, Oseltamivir, Zanavivir, Laninavir, Peramivir within 4 weeks from the start of the study
研究者
相似试验
已完成
不适用
Double-blind Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with InfluenzaInfluenzaJPRN-UMIN000034870Kitano Hospital, Tazuke Kofukai Medical Research Institute. Department of Pediatrics40
已完成
3 期
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsInfluenzaNCT03629184Hoffmann-La Roche173
已完成
3 期
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsInfluenzaNCT06774859Hoffmann-La Roche100
已完成
3 期
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in HouseholdsInfluenzaNCT03969212Hoffmann-La Roche4,138
已完成
3 期
Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe InfluenzaInfluenzaNCT03684044Hoffmann-La Roche363